Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 13Endocrine 6NET 5Genitourinary 5Breast 4Gastrointestinal 3Gynecologic 2CNS 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Sarcoma 11Gliosarcoma 6Glioblastoma 6Central Nervous System Neoplasms 6Brain Neoplasms 5Rhabdomyosarcoma 2Recurrence 2Osteosarcoma 2Gastrointestinal Stromal Tumors 2Bone Neoplasms 2Stomach Neoplasms 1Sarcoma, Synovial 1Sarcoma, Kaposi 1Prostatic Neoplasms 1Neurofibrosarcoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Liposarcoma 1Leiomyosarcoma 1Glioma 1Digestive System Neoplasms 1Chondrosarcoma 1Astrocytoma 1Advanced Solid Tumors 1

Interventions

Cyclophosphamide 17pembrolizumab 12Doxorubicin 10fludarabine 7Irinotecan 7Blood Specimen Collection 7Temozolomide 6Gemcitabine 6Etoposide 6Radiotherapy 5Ifosfamide 5Carboplatin 5Albumin-Bound Paclitaxel 5tecogalan 4cemiplimab 4Vincristine 4Trabectedin 4Paclitaxel 4Nivolumab 4Filgrastim 4Drug Therapy 4Dexamethasone 4Bevacizumab 4pazopanib 3olaparib 3nilotinib 3dostarlimab 3aflibercept 3Therapeutics 3Taxes 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Everolimus × Sarcoma × Clear all
NCT00187174 2015-03-04

Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors

St. Jude Children's Research Hospital

Phase 1 Completed
41 enrolled
CNSSarcoma

Brain Neoplasms, Neoplasms, Recurrence, Rhabdomyosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡